LITERATURE

Treatment and economic burden of mucormycosis in China: Case report review and burden estimation

Jian Y, Wang M, Yu Y, Zhuo Y, Xiao D, Lin S, Xuan J.

Abstract

What is known and objective: Mucormycosis is an opportunistic fungal infection associated with low incidence but high mortality. Few studies have shown the treatment and disease burden of mucormycosis in China. This study aims at collecting all the reported cases to describe the characteristics and treatment patterns and to assess the economic burden of mucormycosis in China.

Print Friendly, PDF & Email Print, PDF, or Email

Publication: https://pubmed.ncbi.nlm.nih.gov/35304764/
Topic(s): Economic Burden
Health Condition(s): Immunology
Year Published: 2022
UAB the University of Alabama at Birmingham home
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.